This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rickert, V. I.
Right arrow Articles by Berenson, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rickert, V. I.
Right arrow Articles by Berenson, A. B.
Related Collections
Right arrow Adolescent Medicine

PEDIATRICS Vol. 103 No. 1 January 1999, p. e6

ELECTRONIC ARTICLE:
Prevalence, Patterns, and Correlates of Voluntary Flunitrazepam Use

Received Jun 23, 1998; accepted Aug 6, 1998.

Vaughn I. Rickert, Constance M. Wiemann, and Abbey B. Berenson

From the Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX.

Objective.    To determine prevalence, patterns, and correlates of voluntary flunitrazepam use in a sample of sexually active adolescent and young adult women 14 to 26 years of age.

Design.    Cross-sectional survey.

Setting.    University-based ambulatory reproductive health clinics.

Patients or Other Participants.    There were 904 women self-identified as white, African-American, or Mexican-American.

Interventions.    None.

Main Outcome Measure.    Lifetime, frequency, patterns, and physical effects of flunitrazepam use.

Results.    Lifetime use was reported by 5.9% (n = 53) of subjects, with frequency of use ranging from 1 to 40 times. Flunitrazepam was taken most often with alcohol (74%), and 49% took this substance with other illicit drugs. Logistic regression analyses controlling for age and race/ethnicity found that users were significantly more likely than were nonusers to report lifetime use of marijuana (odds ratio [OR] = 3.6) or LSD (OR = 5.2), having a peer or partner who used flunitrazepam (OR = 21.7), pressure to use flunitrazepam when out with friends (OR = 2.7), and a mother who had at least a high school education (OR = 2.6). Finally, 10% of voluntary users reported experiencing subsequent physical or sexual victimization.

Conclusions.    Voluntary use of flunitrazepam is becoming a health concern to sexually active young women who reside in the southwestern United States. Young women who have used LSD or marijuana in the past or who have a peer or partner who used this drug appear to be at the greatest risk.  Key words:  flunitrazepam, adolescents, drug use, risk factors, patterns, prevalence.




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
D Spencer
Empyema thoracis: not time to put down the knife
Arch. Dis. Child., October 1, 2003; 88(10): 842 - 843.
[Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
P. Kaul and S. M. Coupey
Clinical Evaluation of Substance Abuse
Pediatr. Rev., March 1, 2002; 23(3): 85 - 94.
[Full Text] [PDF]